You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Stage II-III

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai (ctDNA

Recruiting
  • High-risk Stage II Colorectal Cancer
  • +2 more
  • ctDNA methylation dynamic monitoring
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 14, 2023

High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai

Recruiting
  • High-risk Stage II Colorectal Cancer
  • +2 more
  • mFOLFIRINOX adjuvant chemotherapy
  • mFOLFOX6/XELOX adjuvant chemotherapy
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 12, 2023

Stage II-III Gastric Cancer Trial in Jinan, Qingdao, Yantai (MRD-guided therapy)

Recruiting
  • Stage II-III Gastric Cancer
  • MRD-guided therapy
  • Jinan, Shandong, China
  • +4 more
Nov 27, 2023

Colorectal Cancer, Mismatch Repair-deficient (dMMR), Microsatellite Instability-high (MSI-H) Trial in ZhengZhou (Cadonilimab

Not yet recruiting
  • Colorectal Cancer
  • +3 more
  • Cadonilimab (®), a PD-1/CTLA-4 bi-specific antibody
  • ZhengZhou, Henan, China
    Henan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Jun 18, 2023

Breast Cancer, Cancer of the Breast Trial in Saint Louis (VENTANA MIB-1 Ki67 assay, Oncotype DX® Recurrence Score, PAM50-based

Not yet recruiting
  • Breast Cancer
  • Cancer of the Breast
  • VENTANA MIB-1 Ki67 assay
  • +4 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Apr 18, 2023

Tumors, Rectal Trial (Dostarlimab)

Not yet recruiting
  • Neoplasms, Rectal
  • Dostarlimab
  • (no location specified)
Feb 2, 2023

Laryngeal Cancer Stage II, Laryngeal Cancer Stage III, Carcinoma, Squamous Cell Trial in Amsterdam (radiotherapy, Olaparib)

Active, not recruiting
  • Laryngeal Cancer Stage II
  • +3 more
  • Amsterdam, Netherlands
    The Netherlands Cancer Institute
Sep 27, 2022

Frequency for Stage II/III Gastric Cancer

Completed
  • Gastric Cancer
    • Fuzhou, Fujian, China
      Department of Gastric Surgery
    Jul 18, 2022

    Nasopharyngeal Carcinoma, Nasopharyngeal Tumors, Nasopharyngeal Diseases Trial in Guangzhou (Nimotuzumab, Cisplatin)

    Recruiting
    • Nasopharyngeal Carcinoma
    • +3 more
    • Guangzhou, Guangdong, China
      Sun Yat-sen University Cancer Center
    Nov 3, 2022

    Urothelial Carcinoma Trial in Amsterdam, Nijmegen (Nivolumab)

    Recruiting
    • Urothelial Carcinoma
    • Amsterdam, Netherlands
    • +1 more
    Jul 28, 2022

    Breast Cancer Trial in Shenyang (Pyrotinib maleate, dalpiciclib, Trastuzumab, letrozole)

    Recruiting
    • Breast Cancer
    • Pyrotinib maleate, dalpiciclib, Trastuzumab, letrozole
    • Shenyang, Liaoning, China
      Shengjing Hospital of China Medical University
    Sep 12, 2022

    Stage II Colorectal Cancer AJCC v8, Stage III Colorectal Cancer AJCC v8 Trial in Seattle (procedure, other, behavioral)

    Not yet recruiting
    • Stage II Colorectal Cancer AJCC v8
    • Stage III Colorectal Cancer AJCC v8
    • Biospecimen Collection
    • +4 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jun 26, 2023

    Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma Trial in

    Not yet recruiting
    • Anatomic Stage II Breast Cancer AJCC v8
    • +3 more
    • Biospecimen Collection
    • +7 more
    • Portland, Oregon
      SWOG
    Sep 27, 2023

    The Efficiency for Stage II-III HR+/HER2+ Early Breast Cancer

    Recruiting
    • Breast Cancer
    • Standard Therapy
    • Shenyang, Liaoning, China
      Shengjing Hospital of China Medical University
    Jul 30, 2022

    Role of Immunoscore® in Stage II-III Colorectal Cancer

    Recruiting
    • Colon Adenocarcinoma
    • Immunoscore Colon Test
    • Brasília, Distrito Federal, Brazil
    • +1 more
    Jun 14, 2022

    Rectal Cancer Stage II, Rectal Cancer Stage III Trial in Brussels, Kortrijk, Namur (drug, radiation, procedure)

    Active, not recruiting
    • Rectal Cancer Stage II
    • Rectal Cancer Stage III
    • Nivolumab 10 MG/ML Intravenous Solution
    • +3 more
    • Brussels, Belgium
    • +3 more
    Jul 11, 2022

    Colorectal Cancer Trial (mFOLFOXIRI, mFOLFOX6)

    Not yet recruiting
    • Colorectal Cancer
    • (no location specified)
    Jun 17, 2022

    Rectal Cancer Trial in Chengdu (XELOX)

    Completed
    • Rectal Cancer
    • Chengdu, Sichuan, China
      Guoxue Road 37#,West China Hospital
    Apr 28, 2022

    Resectable Esophageal Cancer, GastroEsophageal Cancer Trial in Madison (combination product, drug, radiation)

    Active, not recruiting
    • Resectable Esophageal Cancer
    • GastroEsophageal Cancer
    • Avelumab combined with Chemoradiation
    • +3 more
    • Madison, Wisconsin
      University of Wisconsin Carbone Cancer Center
    Mar 28, 2022

    dMMR Colorectal Cancer Trial in Beijing (Cadonilimab)

    Recruiting
    • dMMR Colorectal Cancer
    • Beijing, Beijing, China
      National Cancer Center/Cancer Hospital, Chinese Academy of Medic
    Apr 13, 2023

    Colon Adenocarcinoma, Microsatellite Stable Colon Carcinoma, Stage IIB Colon Cancer AJCC v8 Trial (drug, biological, procedure,

    Not yet recruiting
    • Colon Adenocarcinoma
    • +4 more
    • (no location specified)
    Jan 24, 2023

    Stage II-III NSCLC Trial in Shanghai (4cycles(Toripalimab IV 240mg + platinum-based doublet chemo)+13 cycles(Toripalimab IV

    Recruiting
    • Stage II-III Non-small Cell Lung Cancer
    • 4cycles(Toripalimab IV 240mg + platinum-based doublet chemotherapy)+13 cycles(Toripalimab IV 240mg); Biological: Toripalimab
    • 4cycles(Placebo + platinum-based doublet chemotherapy)+13 cycles(Placebo )
    • Shanghai, China
      Shanghai Chest Hospital
    Apr 12, 2022

    Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Rectum, Stage IIA Rectal Cancer Trial in Los Angeles

    Active, not recruiting
    • Mucinous Adenocarcinoma of the Rectum
    • +7 more
    • bevacizumab
    • +4 more
    • Los Angeles, California
      USC Norris Comprehensive Cancer Center
    Aug 5, 2022

    Stage II-III Breast Cancer Trial in Shenyang (cytotoxic chemo (docetaxel or epirubicin or cyclophosphamide or carboplatin),

    Recruiting
    • Stage II-III Breast Cancer
    • cytotoxic chemotherapy (docetaxel or epirubicin or cyclophosphamide or carboplatin)
    • +2 more
    • Shenyang, Liaoning, China
    • +1 more
    Aug 3, 2022

    Osteoarthritis, Knee Trial (Human Umbilical Mesenchymal Stem Cells)

    Not yet recruiting
    • Osteoarthritis, Knee
    • Human Umbilical Mesenchymal Stem Cells
    • (no location specified)
    Oct 8, 2023